Unlocking Proteomics: OlinkTM Reveal Technology at Novogene & Longitudinal Monitoring in CLL
Join experts from Olink and Novogene, a certified service provider of Olink, for an insightful webinar exploring cutting-edge proteomics. This session will provide a comprehensive overview of Olink’s innovative biomarker discovery platform, alongside a detailed walkthrough of the Novogene Olink Reveal workflow. By exploring a real-world case study that longitudinally profiles roughly 1,000 plasma proteins in Chronic Lymphocytic Leukemia (CLL), you will discover how the powerful combination of Olink technology and Novogene’s sequencing expertise empowers researchers to accelerate their multi-omics studies.
• Understand Olink Fundamentals: Grasp the fundamental principles of Olink technology and see how Olink Reveal was used to measure about 1,000 plasma proteins across major biological pathways. • Master the Novogene Workflow: Learn how the Novogene Olink Reveal workflow processes samples from end-to-end to deliver high-quality, reliable data. • Explore Clinical Applications: See how protein changes over time tracked therapeutic responses to BTK inhibitors and revealed candidate biomarkers across two independent longitudinal CLL cohorts.
Griffin Lentsch, PhD — Field Application Scientist Olink Proteomics
Eric Iverson — Senior Sequencing Specialist Novogene Corporation Inc.